NM_004655.4:c.923C>T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_004655.4(AXIN2):c.923C>T(p.Thr308Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,611,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004655.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AXIN2 | ENST00000307078.10 | c.923C>T | p.Thr308Met | missense_variant | Exon 3 of 11 | 1 | NM_004655.4 | ENSP00000302625.5 | ||
ENSG00000266076 | ENST00000577662.1 | n.*1099C>T | non_coding_transcript_exon_variant | Exon 5 of 7 | 2 | ENSP00000462418.1 | ||||
ENSG00000266076 | ENST00000577662.1 | n.*1099C>T | 3_prime_UTR_variant | Exon 5 of 7 | 2 | ENSP00000462418.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000568 AC: 14AN: 246492Hom.: 0 AF XY: 0.0000601 AC XY: 8AN XY: 133168
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1459504Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 725808
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74484
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
- -
The p.T308M variant (also known as c.923C>T), located in coding exon 2 of the AXIN2 gene, results from a C to T substitution at nucleotide position 923. The threonine at codon 308 is replaced by methionine, an amino acid with similar properties. This variant has been reported as de novo in a Chinese patient with non-syndromic oligodontia at age 12 (Wong S et al. Arch. Oral Biol., 2014 Mar;59:349-53). This variant has also been reported in two Finnish patients diagnosed with breast cancer before age 50 (Tervasmäki A et al. Int. J. Cancer, 2018 06;142:2286-2292). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Oligodontia-cancer predisposition syndrome Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 308 of the AXIN2 protein (p.Thr308Met). This variant is present in population databases (rs779083840, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with non-syndromic oligodontia (PMID: 24581859). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 464647). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
AXIN2-related disorder Uncertain:1
The AXIN2 c.923C>T variant is predicted to result in the amino acid substitution p.Thr308Met. This variant has been reported de novo in an individual with non-syndromic oligodontia (Wong et al. 2014. PubMed ID: 24581859). This variant has also been reported in 2 unrelated individuals with breast cancer and a family history of gastric, uterine, and breast cancer (Table S1, Tervasmäki et al. 2018. PubMed ID: 29341116). This variant is reported in 0.057% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-63545671-G-A) and is interpreted as uncertain significance (https://preview.ncbi.nlm.nih.gov/clinvar/variation/464647/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at